Indian Sexually Transmitted Diseases (STD) Diagnostics Market

Indian Sexually Transmitted Diseases (STD) Diagnostics Market Size, Share & Trends Analysis Report by Disease Type (Chlamydia, Syphilis, Gonorrhea, Herpes Simplex Virus (HSV), Human Papilloma Virus (HPV), Human Immunodeficiency Virus (HIV), and Others), by Product (Laboratory Testing Devices, and Point-of-Care (POC) Testing Devices) by End-user (Hospitals and Clinics, Diagnostic Centers, and Homecare) Forecast Period 2019-2025
    Update Available - Forecast 2024-2030   

Published: Feb 2020 | Report Code: OMR2021037 | Category : Medical Devices | Delivery Format: /

Indian STD diagnostics market is growing at a CAGR of around 9.9% during the forecast period. The factors that are driving the sexual transmitted diagnostic test market include increasing prevalence of HIV/HPV infected population across the globe, rising incidences of unprotected sex, and lack of awareness regarding STDs. Moreover, various regulatory authorities have recommended sexually active men and women to have STD screening, which further accelerates the demand for STD testing in the country. Research activities are being carried out to understand the growing prevalence of STDs, particularly Syphilis, among bisexual men and MSMs. All these factors are anticipated to boost the growth of the Indian STD diagnostics market during the forecast period.

Visit for Global Sexually Transmitted Diseases (STD) Diagnostics Market Report at: https://www.omrglobal.com/industry-reports/sexually-transmitted-disease-market-size

Further, for creating awareness regarding the STDs government has started various initiatives and programs that supports the market growth. Some of the projects led by the Indian government includes the Project Sunrise and Project Nirantar. Project sunrise is responsible for improved condition of HIV in north eastern states. The project is focused on key affected populations, particularly people who inject drugs. The project began in 2016 with the central goal of providing treatment to 90% of people by 2020. It will also look to build the capacity of state-level institutions to respond to the needs of people who inject drugs and other key affected populations in order to prevent HIV and expand treatment. Thus, such initiatives are expected to provide the growth of the Indian STD diagnostics market during the forecast period.

The companies which are contributing significantly in the Indian STD diagnostics market include Abbott Laboratories, Inc., AbbVie Inc., Becton, Dickinson and Co., Biocartis NV, Bio-Rad Laboratories, Inc., Danaher Corp., Eli Lilly and Co., F. Hoffmann-La Roche Ltd. and others. The market players are considerably contributing to the market growth by the adoption of various growth strategies including new product launch, merger, and acquisition, collaborations with government, and technological advancements to stay competitive in the market.

Research Methodology

The market study of the Indian STD Diagnostics market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  1. Indian STD Diagnostics Market Research and Analysis by Disease Type
  2. Indian STD Diagnostics Market Research and Analysis by Product
  3. Indian STD Diagnostics Market Research and Analysis by End-user

The Report Covers

  • Comprehensive research methodology of the Indian STD Diagnostics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Indian STD Diagnostics market.
  • Insights about market determinants which are stimulating the Indian STD Diagnostics market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

1. Report Summary

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

2.3. Rules & Regulations

3. Competitive Landscape

3.1. Company Share Analysis 

3.2. Key Strategy Analysis

3.3. Key Company Analysis

3.3.1. Overview

3.3.2. Financial Analysis

3.3.3. SWOT Analysis

3.3.4. Recent Developments

4. Market Determinants 

4.1. Motivators

4.2. Restraints

4.3. Opportunities 

5. Market Segmentation

5.1. Indian STD Diagnostics Market by Disease Type

5.1.1. Chlamydia

5.1.2. Syphilis

5.1.3. Gonorrhea

5.1.4. Herpes Simplex Virus (HSV)

5.1.5. Human Papilloma Virus (HPV)

5.1.6. Human Immunodeficiency Virus (HIV)

5.1.7. Others

5.2. Indian STD Diagnostics Market by Product

5.2.1. Laboratory Testing Devices

5.2.2. Point-of-Care (POC) Testing Devices

5.3. Indian STD Diagnostics Market by End-user

5.3.1. Hospitals and Clinics

5.3.2. Diagnostic Centers

5.3.3. Homecare

6. Company Profiles

6.1. Abbott Laboratories, Inc.

6.2. AbbVie Inc.

6.3. Becton, Dickinson and Co.

6.4. Biocartis NV

6.5. Bio-Rad Laboratories, Inc.

6.6. Danaher Corp.

6.7. Eli Lilly and Co.

6.8. F. Hoffmann-La Roche Ltd.

6.9. Merck KGaA

6.10. Thermo Fisher Scientific, Inc.

1. INDIAN STD DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2018-2025 ($ MILLION)

2. INDIAN STD DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)

3. INDIAN STD DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

1. INDIAN STD DIAGNOSTICS MARKET SHARE BY BIOMARKER DISEASE TYPE, 2018 VS 2025 (%)

2. INDIAN STD DIAGNOSTICS MARKET SHARE BY PRODUCT, 2018 VS 2025 (%)

3. INDIAN STD DIAGNOSTICS MARKET SHARE BY END-USER, 2018 VS 2025 (%)